Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Wood

Showing results (31-40 of 74) with videos related to

Pageof 8
Sort By:
Investigational New Drugs|August 5, 2004
Phase I trial of continuous infusion recombinant human interleukin-4 in patients with cancerNavneet S Majhail, Mohamad Hussein, Thomas E Olencki, et al.
Cancer|October 21, 2010
The impact of tumor burden characteristics in patients with metastatic renal cell carcinoma treated with sunitinibNaveen S Basappa, Paul Elson, Ali-Reza Golshayan, et al.
Cancer Chemotherapy and Pharmacology|October 3, 2007
Phase I trial of PEG-interferon and recombinant IL-2 in patients with metastatic renal cell carcinomaSaby George, Thomas E Hutson, Tarek Mekhail, et al.
The Journal of Urology|November 13, 2007
Antitumor effects of sunitinib or sorafenib in patients with metastatic renal cell carcinoma who received prior antiangiogenic therapyIla Tamaskar, Jorge A Garcia, Paul Elson, et al.
American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses|September 3, 2018
Interprofessional Use and Validation of the AACN Healthy Work Environment Assessment ToolJean Anne Connor, Sonja I Ziniel, Courtney Porter, et al.
American Journal of Clinical Oncology|January 30, 2013
Axitinib for the treatment of metastatic renal cell carcinoma: recommendations for therapy management to optimize outcomesJames Larkin, Mayer Fishman, Laura Wood, et al.
Clinical Genitourinary Cancer|February 12, 2018
Drug Holiday in Metastatic Renal-Cell Carcinoma Patients Treated With Vascular Endothelial Growth Factor Receptor InhibitorsKriti Mittal, Lisa Derosa, Laurence Albiges, et al.
Journal of the National Cancer Institute|January 5, 2007
Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinibBrian I Rini, Ila Tamaskar, Phillip Shaheen, et al.
Clinical Genitourinary Cancer|September 15, 2016
Clinical Effect of Dose Escalation After Disease Progression in Patients With Metastatic Renal Cell CarcinomaMoshe C Ornstein, Laura Wood, Paul Elson, et al.
Langenbeck'S Archives of Surgery|May 28, 2021
Pathology of intraductal papillary mucinous neoplasmsNaziheh Assarzadegan, Elizabeth Thompson, Kevan Salimian, et al.
Pageof 8

Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
Investigational New Drugs|August 5, 2004
Phase I trial of continuous infusion recombinant human interleukin-4 in patients with cancerNavneet S Majhail, Mohamad Hussein, Thomas E Olencki, et al.
Cancer|October 21, 2010
The impact of tumor burden characteristics in patients with metastatic renal cell carcinoma treated with sunitinibNaveen S Basappa, Paul Elson, Ali-Reza Golshayan, et al.
Cancer Chemotherapy and Pharmacology|October 3, 2007
Phase I trial of PEG-interferon and recombinant IL-2 in patients with metastatic renal cell carcinomaSaby George, Thomas E Hutson, Tarek Mekhail, et al.
The Journal of Urology|November 13, 2007
Antitumor effects of sunitinib or sorafenib in patients with metastatic renal cell carcinoma who received prior antiangiogenic therapyIla Tamaskar, Jorge A Garcia, Paul Elson, et al.
American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses|September 3, 2018
Interprofessional Use and Validation of the AACN Healthy Work Environment Assessment ToolJean Anne Connor, Sonja I Ziniel, Courtney Porter, et al.
American Journal of Clinical Oncology|January 30, 2013
Axitinib for the treatment of metastatic renal cell carcinoma: recommendations for therapy management to optimize outcomesJames Larkin, Mayer Fishman, Laura Wood, et al.
Clinical Genitourinary Cancer|February 12, 2018
Drug Holiday in Metastatic Renal-Cell Carcinoma Patients Treated With Vascular Endothelial Growth Factor Receptor InhibitorsKriti Mittal, Lisa Derosa, Laurence Albiges, et al.
Journal of the National Cancer Institute|January 5, 2007
Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinibBrian I Rini, Ila Tamaskar, Phillip Shaheen, et al.
Clinical Genitourinary Cancer|September 15, 2016
Clinical Effect of Dose Escalation After Disease Progression in Patients With Metastatic Renal Cell CarcinomaMoshe C Ornstein, Laura Wood, Paul Elson, et al.
Langenbeck'S Archives of Surgery|May 28, 2021
Pathology of intraductal papillary mucinous neoplasmsNaziheh Assarzadegan, Elizabeth Thompson, Kevan Salimian, et al.
Pageof 8